ANI Pharmaceuticals, Inc. Stock Analysis & AI Score
ANI Pharmaceuticals, Inc. (ANIP) has an ST Score of 57.4 (B-), driven by its Profitability (A) and held back by its Valuation (D-). Analysts rate it Buy with a $99.50 price target (+34.4% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
ANI Pharmaceuticals, Inc. (ANIP) has an ST Score of 57.4 (B-), driven by its Profitability (A) and held back by its Valuation (D-). Analysts rate it Buy with a $99.50 price target (+34.4% upside).
- Strongest
- ProfitabilityA
- Weakest
- ValuationD-
All factor grades
- ProfitabilityA
- GrowthB+
- MomentumB-
- ForecastB-
- Financial StrengthC-
- ValuationD-
- Piotroski7/9
Contact
ANIP stock: frequently asked questions
What is ANIP's ST Score?
ANI Pharmaceuticals, Inc. (ANIP) has an ST Score of 57.4 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ANIP a buy, hold, or sell?
Analysts rate ANIP a Buy, with a price target of $99.50 (+34.4% vs the current price). Our ST Score grades it B- (57.4/100). The ST Score is a data-driven signal, not a recommendation.
What are ANIP's factor grades?
Valuation D-, Profitability A, Financial Strength C-, Momentum B-, Growth B+, Forecast B-.
What is ANIP's valuation grade?
ANI Pharmaceuticals, Inc. (ANIP) earns a valuation grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ANIP's growth grade?
ANI Pharmaceuticals, Inc. (ANIP) earns a growth grade of B+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ANIP's profitability grade?
ANI Pharmaceuticals, Inc. (ANIP) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ANIP's financial strength grade?
ANI Pharmaceuticals, Inc. (ANIP) earns a financial strength grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ANIP?
The average analyst price target for ANI Pharmaceuticals, Inc. (ANIP) is $99.50 from 10 analysts, which is +34.4% versus the recent price of $74.04.
What is ANIP's Piotroski score?
ANI Pharmaceuticals, Inc. (ANIP) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.